Corcept's Q2 2025 saw 60% therapy demand growth despite bottlenecks. Despite near-term operational risks, we maintain ...

Brazilian oil firm Petrobras on Thursday announced dividends and interest on equity to shareholders of 8.66 billion reais ($1 ...

Brazilian oil firm Petrobras on Thursday announced dividends and interest on equity to shareholders of 8.66 billion reais ($1 ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

Net debt and capitalization -- $6.9 million in cash as of June 30, 2025, $6.6 million in debt facilities available as of June ...

Data Center Load Agreements -- 580 megawatts of data center load under signed electric service agreements at the electric ...

Novo Nordisk has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly ...

Warner Bros. Discovery said second quarter profit was boosted by HBO Max international expansion and "Minecraft Movie" ...

Ultragenyx Pharmacutical reported second-quarter revenue increased 13% year over year. The Novato-based company aims for ...

Despite progress on several clinical programs and tighter cost controls, there was a major decline in cash reserves, with cash and cash equivalents (GAAP) decreasing from $49.0 million as of December ...

Total sales-- $498.7 million for the fiscal second quarter ended June 30, 2025, up 11.9% year-over-year and 4.7% sequentially, establishing a new quarterly record. Adjusted EBITDA-- Adjusted EBITDA ...

Vital Energy (NYSE: VTLE) reported a $582.6 million net loss in Q2 2025 due to a substantial impairment charge, but ...